Timothy A. Springer - Director, 10%+ Owner at Cartesian Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Stock Symbol
RNAC on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Timothy A. Springer - trading volume in the past year for Cartesian Therapeutics, Inc.

Holdings reported by Timothy A. Springer for Cartesian Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 4.38M $55.7M $12.72 Aug 12, 2024 Direct
Series B Non-Voting Convertible Preferred Stock 1.64M $32.7M $20.00 Jul 2, 2024 Direct
Common Stock 1.93M $24.5M $12.72 Aug 12, 2024 Indirect
Series B Non-Voting Convertible Preferred Stock 721K $14.4M $20.00 Jul 2, 2024 Indirect
Common Stock 11.5K $146K $12.72 Aug 12, 2024 By wife
Series B Non-Voting Convertible Preferred Stock 1.31K $26.1K $20.00 Jul 2, 2024 By wife
Stock Option (Right to Buy) 7.6K $6K $0.79 Apr 8, 2024 Direct Common Stock 7.6K
Warrant (Right to Buy) 167K Apr 8, 2024 Indirect Common Stock 167K
Series A Convertible Preferred Stock 124K Nov 15, 2023 Direct
Series A Convertible Preferred Stock 24.8K Nov 15, 2023 Indirect
Series A Non-Voting Convertible Preferred Stock 0 Apr 8, 2024 Direct
Series A Non-Voting Convertible Preferred Stock 0 Apr 8, 2024 Indirect

Transactions reported by Timothy A. Springer for Cartesian Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.